← Leaderboards
Shenglong Zhang
New York Inst Of Technology
$3,247,093
Attributed
$3,531,493
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,531,493 · 5
By mechanism
R01$1,991,105 · 1
R41$621,588 · 2
R21$568,800 · 1
R56$350,000 · 1
Top collaborators
- Wenjia Li3 shared
Others in their field
Other Emerging Leaders on “Mass Spectrum Analysis”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
- Gregory L Hura · University Of Calif-Lawrenc Berkeley Lab$11,347,896
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Danielle L Swaney · University Of California, San Francisco$8,594,269
Research focus
Mass Spectrum AnalysisSamplingTechnologyTranscriptome SequencingModificationLocationComplementary DnaNucleotidesBaseNext GenerationNon-Insulin-Dependent Diabetes MellitusResolutionStoichiometryPreparationAffectAmericanMalignant Breast NeoplasmAlgorithmsTranscriptomeSiteLengthObesityProteomicsRna Sequences
Grant awards (10)
Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications$660,378
R01 · FY2025 · HG · contact PI
High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.$406,500
R41 · FY2024 · HG · contact PI
Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications$354,295
R01 · FY2024 · HG · contact PI
Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications$299,486
R01 · FY2024 · HG · contact PI
Exhaustive de novo sequencing of every RNA in a sample by a layer-by-layer mass spectrometry ladder intensity approach.$215,088
R41 · FY2024 · HG · contact PI
Development of Next-Generation Mass Spectrometry-based de novo RNA Sequencing for all Modifications$676,946
R01 · FY2023 · HG · contact PI
LC/MS-Based Direct RNA Sequencing with Concomitant Capability to Sequence Multiple Base Modifications at Single-base Resolution$350,000
R56 · FY2020 · HG · contact PI
Development of LC/MS-Based Direct RNA Sequencing with Concomitant Basecalling and Modification Analysis Capability$177,750
R21 · FY2019 · HG · contact PI
Development of LC/MS-Based Direct RNA Sequencing with Concomitant Basecalling and Modification Analysis Capability$213,300
R21 · FY2018 · HG · contact PI
Development of LC/MS-Based Direct RNA Sequencing with Concomitant Basecalling and Modification Analysis Capability$177,750
R21 · FY2017 · HG · contact PI